Search the compound plus pharmacokinetics
Not the plant, the compound. Icariin rather than horny goat weed, eurycomanone rather than tongkat ali. The study, if it exists, will be filed under the molecule.
The Absorption Problem
Every argument about supplement doses assumes the compound reaches your blood. Sometimes it does not, and the study that checks is the one nobody reads.
Quick answer
A pharmacokinetic study measures what actually appears in the blood after a dose is swallowed, rather than what was in the capsule. It is the step between a dose and an effect, and it is skipped in almost every supplement marketing argument. Where a compound is poorly absorbed, increasing the dose does not solve the problem, and a trial that tested a sixteenfold dose range without moving blood levels has answered the dosing question permanently.
The step between a dose and an effect
Almost every argument you will read about supplement dosing takes the same shape. The research used 500 mg, this product has 100 mg, therefore this product is underdosed. It is a reasonable argument and it rests on an assumption nobody states.
The assumption is that the compound gets into you. That swallowing it puts it in your bloodstream, where it can reach the tissue it is supposed to act on, at a concentration that does something.
For most nutrients that assumption is fine. Vitamin C, zinc, magnesium and the B vitamins are absorbed well enough that a dose argument is a real argument. The research on them measured blood levels decades ago and the answer is known.
For a number of plant compounds the assumption is not fine at all, and the dose argument collapses before it starts. If almost nothing crosses from your gut into your blood, then 100 mg and 1,600 mg produce the same result, which is approximately nothing, and arguing about which is on the label misses the point entirely.
What a pharmacokinetic study actually does
These studies are unglamorous and they are the ones worth finding. A group of people swallow a known dose. Blood is drawn at intervals over the following hours. The compound is measured in each sample.
What comes out is a curve: how high the concentration got, how long it took, how long it stayed. Those numbers are the bridge between what was in the capsule and what could possibly have happened in the body.
A well-designed one is randomised, double-blind and placebo-controlled, just like an efficacy trial, and it often tests several doses at once so that the relationship between dose and blood level can be seen rather than assumed.
The result that stops a dosing argument dead is a flat curve. If blood levels barely move as the dose rises many-fold, then the limiting factor is not the amount swallowed. It is the absorption, and the absorption is a property of the molecule rather than of the label.
This is the specific reason we go looking for pharmacokinetic data on any botanical before writing about how much of it a product contains.
The question to ask about any botanical
Has anyone measured this compound in human blood after an oral dose? For the well-studied ingredients the answer is yes and the numbers are public. For many, the answer is no, and every dosing claim about them is standing on air.
Why a compound fails to get into you
Four ordinary reasons, none of them exotic. Any one of them can flatten the curve.
| The obstacle | What happens | What it means for a label |
|---|---|---|
| Poor solubility | The compound does not dissolve well enough in the gut to cross the intestinal wall at all | The amount on the label is largely irrelevant. Formulation, not dose, is the variable that matters. |
| First-pass metabolism | Absorbed, then broken down by the liver before reaching general circulation | Blood levels stay low regardless of dose. Some compounds are almost entirely removed on the first pass. |
| Efflux transporters | The intestinal wall actively pumps the compound back out as fast as it comes in | A saturable process, which is why some compounds do respond to very large doses and others never do. |
| Gut bacteria | The compound is metabolised by the microbiome before absorption, into something else entirely | Results vary enormously between individuals, because microbiomes do. A group average can hide two different populations. |
Formulation work exists to get around all four: liposomal preparations, phospholipid complexes, piperine, nanoemulsions. Some of it is genuine and some of it is marketing, and a label that does not name a specific delivery technology has not done any of it.
About the product behind this blog
Horse Honey Advanced Formula is a men’s performance capsule: eight ingredients sharing one 1,200 mg Test Boost Proprietary Blend, with no individual amounts published. We print the arithmetic the label leaves out.
Order NowRead the label firstThe clearest example in the men's category
Horny goat weed is on a very large proportion of men's supplement labels, including the one this site sells. Its active compound is icariin, and the dosing arguments about it are everywhere.
In 2019 a randomised, double-blind, placebo-controlled human study gave orally administered icariin across a range of doses from 100 mg to 1,680 mg, and measured what appeared in the blood.
The result was very low or undetectable blood levels, with nearly all samples below 1 ng/mL. A sixteenfold dose range, and the curve stayed on the floor.
Read that carefully, because it does something unusual: it settles the dosing question rather than advancing it. If 1,680 mg does not produce measurable blood levels, then no label in this category carries enough, and asking whether a particular product has 200 mg or 400 mg of the extract is asking the wrong question.
It does not prove the ingredient does nothing. Local effects in the gut, metabolites the study did not measure, and long-term accumulation are all live possibilities. It does mean that the standard story, that icariin circulates and acts on tissue, has a measurement problem sitting in front of it.
What to do with this when reading a label
Three practical moves, in the order we use them.
Check whether the trial measured blood
An efficacy trial that found an effect without measuring blood levels is still evidence. One that measured both is far stronger, because it connects the dose to the outcome.
Discount unnamed delivery claims
Enhanced absorption, advanced bioavailability and high potency mean nothing without a named technology. Liposomal, phytosome and piperine are claims that can be checked. Advanced is not.
The honest caveat on all of this
Absence of measurable blood levels is not proof of absence of effect, and a single pharmacokinetic study is one study. The reason we weight this one heavily is its design: randomised, double-blind, placebo-controlled, across a sixteenfold dose range, measuring the compound directly. That is a stronger piece of evidence than most of what is cited in this category in either direction.
The one-sentence version
Before arguing about whether a label carries enough of an ingredient, check whether anyone has measured that ingredient in human blood after an oral dose. If the answer is that blood levels stayed near zero across a wide dose range, the dosing argument is already over.
What good evidence looks like when it exists
The point of this article is not that botanical research is worthless. It is that the quality varies enormously, and the variation is legible if you know what to look at.
The strongest shape for an ingredient is two studies that agree: a pharmacokinetic study showing the compound reaches the blood at a given dose, and an efficacy trial at that same dose showing an outcome. When both exist, the chain from capsule to effect is complete.
The next best is a well-designed efficacy trial that specifies the extract, the standardisation and the dose, even without the blood measurements. A randomised, double-blind, placebo-controlled trial in a defined population is real evidence whatever else is missing.
Below that sit open-label studies, animal work, in-vitro results and traditional use. Each has a role, and none of them supports a dosing claim on a bottle.
The reason to know this hierarchy is that marketing collapses it. A sentence beginning studies show can be resting on any tier, and the tier is what determines whether the sentence means anything.
Where to find this for yourself
Search the compound name together with pharmacokinetics or bioavailability, rather than the plant name with benefits. The first search returns measurements; the second returns marketing. It is the single most useful change you can make to how you research an ingredient.